This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Results Obtained in 84 Patients Between 1961 and 1982

Walter F. Lever, MD; Gundula Schaumburg-Lever, MD

Arch Dermatol. 1984;120(1):44-47.

Abstract
• A review of the treatment of 84 patients with pemphigus vulgaris between 1961 and 1982 showed that 47 of the 84 patients were free of lesions and not receiving treatment as of Jan 1, 1983. Twenty-two of the patients had been without lesions and treatment for more than five years. There had been no disease- or treatment-related fatalities since 1976. Two types of treatment have been used in recent years: in severe cases an initial course of large daily doses of prednisone (200 to 400 mg) was given for six to ten weeks. This was followed by combined treatment with small, alternate-day doses of prednisone plus a daily dose of an immunosuppressant agent, usually azathioprine. In mild, relatively stable cases the combined form of treatment was given from the beginning. The use of intermediate doses of prednisone, ie, doses between 40 mg every other day and 200 mg/day, is discouraged as potentially hazardous.

(Arch Dermatol 1984;120:44-47)

Author Affiliations
From the Departments of Dermatology, Tufts University School of Medicine and New England Medical Center, Boston.

Footnotes
Accepted for publication July 1, 1983.

Reprint requests to Thielallee 10d, D-1000 Berlin 33, West Germany (Dr Lever).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Randomized Controlled Trial of Adjuvant Oral Dexamethasone Pulse Therapy in Pemphigus Vulgaris: PEMPULS Trial
Mentink et al.
Arch Dermatol 2006;142:570-576.
ABSTRACT | FULL TEXT  

Pemphigus Vulgaris IgG and Methylprednisolone Exhibit Reciprocal Effects on Keratinocytes
Nguyen et al.
J. Biol. Chem. 2004;279:2135-2146.
ABSTRACT | FULL TEXT  

PEMPHIGUS VULGARIS: UPDATE ON ETIOPATHOGENESIS, ORAL MANIFESTATIONS, AND MANAGEMENT
Scully and Challacombe
CROBM 2002;13:397-408.
ABSTRACT | FULL TEXT  

Suggested Rationale for Prevention and Treatment of Glucocorticoid-Induced Bone Loss in Dermatologic Patients
Yosipovitch et al.
Arch Dermatol 2001;137:477-481.
ABSTRACT | FULL TEXT  

The Adjuvant Therapy of Pemphigus: An Update
Bystryn and Steinman
Arch Dermatol 1996;132:203-212.
ABSTRACT  

Management of Acquired Bullous Skin Diseases
Fine
NEJM 1995;333:1475-1484.
FULL TEXT  

Treatment of Pemphigus Vulgaris With Pulse Intravenous Cyclophosphamide
Pandya and Sontheimer
Arch Dermatol 1992;128:1626-1630.
ABSTRACT  

Resident's Page
FECHNER
Arch Otolaryngol Head Neck Surg 1991;117:686-689.
ABSTRACT  

Controlled Study of Plasma Exchange in Pemphigus
Guillaume et al.
Arch Dermatol 1988;124:1659-1663.
ABSTRACT  

Hyperinfection With Strongyloides During Treatment of Pemphigus Vulgaris
Sarubbi
Arch Dermatol 1987;123:864-865.
ABSTRACT  

Dermatologic Problems in the Intensive Care Unit: Part I
Berman and Silvestri
J Intensive Care Med 1986;1:15-28.
ABSTRACT